Grifols tops earnings, revenue estimates despite foreign-exchange headwinds

Published 30/07/2025, 11:30
© Reuters

Investing.com - Shares in Grifols (BME:GRLS) were higher in mid-morning trading in Europe after the Spanish biopharma firm delivered solid second-quarter results despite large foreign exchange headwinds.

The Barcelona-based firm also reiterated its annual guidance, adding that it is seeing "strong underlying momentum across its core businesses" heading into the second half of the 2025 calendar year.

"While the recent depreciation of the U.S. dollar presents a headwind to reported Revenue and EBITDA in the second half, the impact on Group Profit, leverage and Free Cash Flow pre-M&A is expected to be broadly neutral," Grifols said in a statement.

"The Group expects to largely mitigate this headwind through a combination of the benefit of underlying business momentum and targeted cost levers."

Revenues in the second quarter rose by 4% compared to a year earlier to 1.89 billion euros, while adjusted net income surged by 27% to 133 million euros. Both metrics were above consensus expectations, according to data from BofA Securities.

Grifols showed "[v]ery strong underlying biopharma performance, with solid market demand and Grifols outperforming [the] market," the BofA analysts led by Charlie Haywood said in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.